Sort
15,273 grants matching “antimicrobial resistance”
Development of customized aluminosilicates as complementary topical therapeutics for wound infections
$210,971Shelley E Haydel · Arizona State University-Tempe Campus · R21 · FY2016 · AI
Minimizing bloodstream infection detection time using laser light-scattering
$210,937Andrew P Tomaras · Bacterioscan, Inc. · R43 · FY2018 · AI
Infectious Diseases Fellowship Program
$210,927Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2019 · AI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases
$210,895Michael J. Dawson · Spero Therapeutics, Inc. · N01 · FY2019 · AI
Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach
$210,844Kim Chan · University Of Sydney · R33 · FY2020 · AI
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,830Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2017 · GM
Global Mechanisms of Bacteriocin Resistance in Listeria
$210,750Kurt W Miller · University Of Wyoming · R21 · FY2006 · AI
Towards the Translation of Synergistic Phage-Polymyxin Combination Therapy against Pandrug-resistant Klebsiella pneumoniae: A Systems Approach
$210,731Jian Li · Monash University · R21 · FY2021 · AI
PSEUDOMONAS AUTOINDUCER BIOSYNTHESIS AND DRUG DISCOVERY
$210,725Colorado State University-Fort Collins · R01 · FY2000 · GM
Functional Characterization of the Site Specific Residues in Mutacin 1140
$210,506Frank William Austin · Mississippi State University · R15 · FY2008 · AI
Role of Pin-domain toxins in Mycobacterium tuberculosis pathogenesis
$210,489James Scott Butler · University Of Rochester · R21 · FY2010 · AI
Prevention of Candida biofilms by localized delivery of aurein analogues
$210,436Sean P Palecek · University Of Wisconsin-Madison · R21 · FY2017 · AI
Bio-engineered Cell Therapy to Treat Candidiasis
$210,375Pappanaicken Rangasamy Kumaresan · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · AI
Molecular Targets in Peptidoglycan Synthesis
$210,375Medical University Of South Carolina · R01 · FY2003 · GM
Design of C. parvum and T. gondii DHFR-TS Inhibitors
$210,373Amy C. Anderson · University Of Connecticut Storrs · R01 · FY2006 · GM
Administrative Core
$210,354Myron Max Levine · University Of Maryland Baltimore · U19 · FY2019 · AI
Prevention of Candida biofilms by localized delivery of aurein analogues
$210,314Sean P Palecek · University Of Wisconsin-Madison · R21 · FY2018 · AI
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,167Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2020 · GM
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,167Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2018 · GM
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,167Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2019 · GM
Horizontal Genetic Transfer In Staphylococci
$210,140Ashley Robinson · New York Medical College · R01 · FY2007 · GM
Apramycin scaffold exploration using novel glycochemistry and SAR studies to enhance activity against Acinetobacter baumannii and other multidrug-resistant Gram-negative pathogens
$210,119James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2020 · AI
Small molecule inhibitors of lytic transglycosylase to potentiate beta-lactam antibiotics
$210,105Focco Van Den Akker · Case Western Reserve University · R21 · FY2021 · AI
Structure,Function, and Inhibition of Beta-lactamases
$210,095Northwestern University · R01 · FY2002 · GM
Rapid screening for modes-of-action of M. tuberculosis inhibitors by high-throughput metabolic fingerprinting
$210,086Michael Berney · Albert Einstein College Of Medicine · R21 · FY2019 · AI